Page last updated: 2024-08-17

bromodeoxyuridine and Mesothelioma

bromodeoxyuridine has been researched along with Mesothelioma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abramowski, V; Alekov, A; Giovannini, M; Hanemann, CO; Lerche, H; Utermark, T1
Fitzpatrick, DR; Marzo, AL; Robinson, BW; Scott, B1

Other Studies

2 other study(ies) available for bromodeoxyuridine and Mesothelioma

ArticleYear
Quinidine impairs proliferation of neurofibromatosis type 2-deficient human malignant mesothelioma cells.
    Cancer, 2003, Apr-15, Volume: 97, Issue:8

    Topics: Blotting, Western; Bromodeoxyuridine; Cell Division; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; DNA Primers; Enzyme Inhibitors; Humans; Immunoenzyme Techniques; Mesothelioma; Neoplasms, Mesothelial; Neurofibromatosis 2; Neurofibromin 2; Patch-Clamp Techniques; Polymerase Chain Reaction; Quinidine; Schwann Cells; Tumor Cells, Cultured

2003
Antisense oligonucleotides specific for transforming growth factor beta2 inhibit the growth of malignant mesothelioma both in vitro and in vivo.
    Cancer research, 1997, Aug-01, Volume: 57, Issue:15

    Topics: Animals; Bromodeoxyuridine; Cell Division; Female; Injections, Intralesional; Injections, Subcutaneous; Mesothelioma; Mice; Mice, Inbred CBA; Neoplasm Transplantation; Oligonucleotides, Antisense; RNA, Messenger; Survival Rate; Time Factors; Transforming Growth Factor beta; Tumor Cells, Cultured

1997